Cleared Traditional

K190956 - SCS 17-01

K190956 is an FDA 510(k) clearance for SCS 17-01, manufactured by Anika Therapeutics, Inc.. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 294-day FDA review.

K190956 · Anika Therapeutics, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2020
Decision
294d
Days
Class 2
Risk

K190956 is an FDA 510(k) clearance for the SCS 17-01. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Anika Therapeutics, Inc. (Beford, US). The FDA issued a Cleared decision on January 30, 2020 after a review of 294 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Anika Therapeutics, Inc. devices

FDA 510(k) Submission Details - K190956

510(k) Number K190956 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 11, 2019
Decision Date January 30, 2020
Days to Decision 294 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
172d slower than avg
Panel avg: 122d · This submission: 294d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 290
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K190956.
DB-Orthopedics
K200752 · Dimensional Bioceramics, LLC · Apr 2020
Agilon Strip
K193487 · Biogennix, LLC · Mar 2020
Agilon Moldable
K193168 · Biogennix, LLC · Feb 2020
Altapore
K192363 · Baxter Healthcare Corporation · Jan 2020
Resorbable Mesh Device
K193040 · SeaSpine Orthopedics Corporation · Nov 2019
NuVasive AttraX Putty
K191974 · Nu Vasive, Incorporated · Nov 2019